vs

Side-by-side financial comparison of Ispire Technology Inc. (ISPR) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

Ispire Technology Inc. is the larger business by last-quarter revenue ($20.3M vs $14.5M, roughly 1.4× SS Innovations International, Inc.). SS Innovations International, Inc. runs the higher net margin — -17.0% vs -32.5%, a 15.5% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs -51.5%). SS Innovations International, Inc. produced more free cash flow last quarter ($-3.2M vs $-4.0M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs -17.8%).

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

ISPR vs SSII — Head-to-Head

Bigger by revenue
ISPR
ISPR
1.4× larger
ISPR
$20.3M
$14.5M
SSII
Growing faster (revenue YoY)
SSII
SSII
+130.6% gap
SSII
79.1%
-51.5%
ISPR
Higher net margin
SSII
SSII
15.5% more per $
SSII
-17.0%
-32.5%
ISPR
More free cash flow
SSII
SSII
$802.1K more FCF
SSII
$-3.2M
$-4.0M
ISPR
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
-17.8%
ISPR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
ISPR
ISPR
SSII
SSII
Revenue
$20.3M
$14.5M
Net Profit
$-6.6M
$-2.5M
Gross Margin
17.1%
43.9%
Operating Margin
-33.9%
-3.7%
Net Margin
-32.5%
-17.0%
Revenue YoY
-51.5%
79.1%
Net Profit YoY
17.4%
-28.5%
EPS (diluted)
$-0.12
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISPR
ISPR
SSII
SSII
Q4 25
$20.3M
$14.5M
Q3 25
$30.4M
$12.8M
Q2 25
$20.1M
$10.0M
Q1 25
$26.2M
$5.1M
Q4 24
$41.8M
$8.1M
Q3 24
$39.3M
$4.4M
Q2 24
$37.3M
$4.5M
Q1 24
$30.0M
$3.6M
Net Profit
ISPR
ISPR
SSII
SSII
Q4 25
$-6.6M
$-2.5M
Q3 25
$-3.3M
$-3.7M
Q2 25
$-14.8M
$-256.7K
Q1 25
$-10.9M
$-5.7M
Q4 24
$-8.0M
$-1.9M
Q3 24
$-5.6M
$-3.2M
Q2 24
$-3.5M
$-4.1M
Q1 24
$-5.9M
$-9.8M
Gross Margin
ISPR
ISPR
SSII
SSII
Q4 25
17.1%
43.9%
Q3 25
17.0%
48.1%
Q2 25
12.3%
59.1%
Q1 25
18.2%
21.2%
Q4 24
18.5%
48.9%
Q3 24
19.5%
52.8%
Q2 24
28.3%
31.9%
Q1 24
20.4%
20.0%
Operating Margin
ISPR
ISPR
SSII
SSII
Q4 25
-33.9%
-3.7%
Q3 25
-8.9%
-14.3%
Q2 25
-72.7%
1.0%
Q1 25
-40.4%
-115.6%
Q4 24
-17.6%
-22.7%
Q3 24
-13.4%
-73.1%
Q2 24
-9.2%
-90.9%
Q1 24
-18.8%
-270.3%
Net Margin
ISPR
ISPR
SSII
SSII
Q4 25
-32.5%
-17.0%
Q3 25
-10.7%
-29.0%
Q2 25
-73.4%
-2.6%
Q1 25
-41.5%
-111.0%
Q4 24
-19.1%
-23.7%
Q3 24
-14.2%
-74.0%
Q2 24
-9.4%
-91.8%
Q1 24
-19.7%
-270.5%
EPS (diluted)
ISPR
ISPR
SSII
SSII
Q4 25
$-0.12
$-0.01
Q3 25
$-0.06
$-0.02
Q2 25
$-0.26
$0.00
Q1 25
$-0.19
$-0.03
Q4 24
$-0.14
$-0.01
Q3 24
$-0.10
$-0.02
Q2 24
$-0.07
$-0.02
Q1 24
$-0.11
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISPR
ISPR
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$17.6M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$-7.7M
$38.2M
Total Assets
$84.4M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISPR
ISPR
SSII
SSII
Q4 25
$17.6M
$3.2M
Q3 25
$22.7M
$5.7M
Q2 25
$24.4M
$11.4M
Q1 25
$23.5M
$15.9M
Q4 24
$34.4M
$466.5K
Q3 24
$37.7M
$220.4K
Q2 24
$35.1M
$608.2K
Q1 24
$39.5M
$948.1K
Stockholders' Equity
ISPR
ISPR
SSII
SSII
Q4 25
$-7.7M
$38.2M
Q3 25
$-1.8M
$39.6M
Q2 25
$604.7K
$42.0M
Q1 25
$14.8M
$40.6M
Q4 24
$24.2M
$13.5M
Q3 24
$30.7M
$13.7M
Q2 24
$34.5M
$14.8M
Q1 24
$35.9M
$16.7M
Total Assets
ISPR
ISPR
SSII
SSII
Q4 25
$84.4M
$74.2M
Q3 25
$96.4M
$69.6M
Q2 25
$102.2M
$70.0M
Q1 25
$115.7M
$63.5M
Q4 24
$132.0M
$42.4M
Q3 24
$129.0M
$39.0M
Q2 24
$122.6M
$35.7M
Q1 24
$108.0M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISPR
ISPR
SSII
SSII
Operating Cash FlowLast quarter
$-4.0M
$-1.5M
Free Cash FlowOCF − Capex
$-4.0M
$-3.2M
FCF MarginFCF / Revenue
-19.9%
-22.3%
Capex IntensityCapex / Revenue
0.3%
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.2M
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISPR
ISPR
SSII
SSII
Q4 25
$-4.0M
$-1.5M
Q3 25
$-1.2M
$-7.5M
Q2 25
$4.7M
$-3.5M
Q1 25
$-12.5M
$-6.1M
Q4 24
$-3.2M
$-3.3M
Q3 24
$3.6M
$-2.5M
Q2 24
$-1.4M
$-1.0M
Q1 24
$3.4M
$-2.7M
Free Cash Flow
ISPR
ISPR
SSII
SSII
Q4 25
$-4.0M
$-3.2M
Q3 25
$-1.2M
$-8.2M
Q2 25
$3.7M
$-3.8M
Q1 25
$-12.7M
$-7.0M
Q4 24
$-3.2M
$-3.4M
Q3 24
$3.3M
$-4.2M
Q2 24
$-2.2M
$-3.1M
Q1 24
$3.3M
$-2.8M
FCF Margin
ISPR
ISPR
SSII
SSII
Q4 25
-19.9%
-22.3%
Q3 25
-3.9%
-64.1%
Q2 25
18.6%
-37.7%
Q1 25
-48.4%
-136.2%
Q4 24
-7.7%
-41.7%
Q3 24
8.5%
-96.9%
Q2 24
-5.9%
-69.5%
Q1 24
10.9%
-76.9%
Capex Intensity
ISPR
ISPR
SSII
SSII
Q4 25
0.3%
11.8%
Q3 25
0.0%
5.9%
Q2 25
4.8%
3.2%
Q1 25
0.7%
17.0%
Q4 24
0.1%
1.5%
Q3 24
0.7%
38.8%
Q2 24
2.0%
46.8%
Q1 24
0.3%
3.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISPR
ISPR

Segment breakdown not available.

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons